Furthermore, the lack of transgender status monitoring can limit the accuracy of our interpretations and calculations regarding medication safety​11​. To ease this burden, more high-quality education for healthcare professionals oriented to patient safety is needed. This concept can be applied to the use or desired use of hormone therapies in transgender patients. This demonstrates the importance of building an open dialogue in healthcare in the interests of patient-centred safety and care. Ultimately, it is time to recognise that trans-inclusive care is person-centred care, and therefore the outcomes and safety of this population are everyone’s responsibility.

Source: Los Angeles Times October 16, 2024 14:37 UTC